ArticleMolecular biology reports2024

Palbociclib inhibits the progression of head and neck cancer and improves the Cetuximab response under specific condition in vitro and in vivo.

Ruichen Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.